Figure 1
Spatial Analysis of patients seen at the UF-NFIND. Geographical distribution of insured and uninsured persons seen at the UF-NFIND and their relationship to the nearest movement disorders center of excellence.
Table 1
Patient Demographics of Underserved Movement Disorder Persons.
| DIAGNOSIS | N | MEDICAID | UNINSURED | FEMALE (%) | MEAN AGE (YEARS) +/– SD | REHABILITATION (%) | BOTULINUM TOXIN (%) | DBS (%) |
|---|---|---|---|---|---|---|---|---|
| Tic disorders | 67 | 64 | 3 | 22 (32.8) | 19.9 +/– 11.6 | 28 (41.8) | 0 (0.0) | 1 (1.5) |
| Dystonia | 65 | 46 | 19 | 41 (63.1) | 42.6 +/– 18.2 | 17 (26.2) | 34 (52.3) | 10 (15.4) |
| Parkinson’s disease | 52 | 20 | 32 | 23 (44.2) | 65.2 +/– 11.1 | 29 (55.8) | 3 (5.8) | 10 (19.2) |
| Essential Tremor | 41 | 33 | 8 | 18 (43.9) | 53.1 +/– 13.6 | 11 (26.8) | 1 (2.4) | 1 (2.4) |
| Tremor | 35 | 30 | 5 | 24 (68.6) | 45.3 +/– 17.6 | 5 (14.3) | 0 (0.0) | 1 (2.9) |
| Ataxia | 25 | 16 | 9 | 15 (60.0) | 46.0 +/– 16.4 | 10 (40.0) | 1 (4.0) | 0 (0.0) |
| Huntington’s disease | 17 | 12 | 5 | 7 (41.2) | 45.9 +/– 13.0 | 12 (70.6) | 0 (0.0) | 0 (0.0) |
| Parkinsonism NOS | 10 | 7 | 3 | 2 (20.0) | 62.4 +/– 12.1 | 2 (20.0) | 0 (0.0) | 0 (0.0) |
| Myoclonus | 8 | 7 | 1 | 5 (62.5) | 43.1 +/– 13.6 | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Stereotypies | 7 | 7 | 0 | 1 (10.0) | 31.7 +/– 20.3 | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Tardive syndromes | 7 | 5 | 2 | 5 (71.4) | 48.3 +/– 13.1 | 1 (14.3) | 2 (28.6) | 0 (0.0) |
| Chorea | 5 | 5 | 0 | 4 (80.0) | 44.8 +/– 14.4 | 1 (20.0) | 0 (0.0) | 0 (0.0) |
| Other | 16 | 9 | 7 | 9 (56.3) | 52.25 +/– 21.5 | 6 (37.5) | 0 (0.0) | 0 (0.0) |
| All patients | 355 | 261 | 94 | 176 (49.6) | 44.4 +/– 20.5 | 122 (34.4) | 41 (11.5) | 23 (6.5) |
[i] SD – Standard deviation; NOS – not otherwise specified; DBS – Deep Brain Stimulation.
Table 2
Average distances from Medicaid/self-pay patients to movement disorders centers according to disease type.
| DIAGNOSIS | N (%) | DISTANCE TO NEAREST CENTER, KM MEDIAN (IQR) | Distance to UF, Km Median (IQR) | P-VALUE† |
|---|---|---|---|---|
| Ataxia | 25 | 99.76 (54.69–219.18) | 165.85 (69.55–328.48) | 0.003* |
| Chorea | 5 | 77.033 (38.433–221.440) | 80.004 (38.43–221.44) | 1 |
| Dystonia | 65 | 70.70 (27.79–158.95) | 119.76 (61.53–218.23) | <0.001* |
| ET | 41 | 62.53 (38.43–81.17) | 62.53 (38.43–91.11) | 0.096 |
| HD | 17 | 71.61 (52.39–144.17) | 159.01 (71.61–182.36) | 0.014* |
| Myoclonus | 8 | 51.553 (34.59–74.00) | 59.649 (44.61–99.74) | 0.371 |
| PD | 52 | 70.580 (25.68–148.98) | 168.142 (48.83–234.79) | <0.001* |
| Park. NOS | 10 | 58.611 (9.25–76.47) | 66.06 (18.19–118.23) | 0.371 |
| Stereotypies | 7 | 6.016 (4.26–23.12) | 6.016 (4.26–104.80) | 0.371 |
| Tardive | 7 | 81.90 (50.52–362.6) | 226.28 (75.59–377.62) | 0.371 |
| Tic disorders | 67 | 63.31 (30.12–100.78) | 69.66 (44.60–119.72) | 0.003* |
| Tremor | 35 | 42.724 (6.562–74.52) | 61.138 (10.28–87.90) | 0.009* |
[i] ET: Essential Tremor.
HD: Huntington Disease.
PD: Parkinson’s Disease.
NOS: Not-otherwise specified.
† Paired-samples Wilcoxon (signed-rank) p-value.
* Comparisons found to be statistically significant.